Christopher Kurtz

Christopher Kurtz

Directeur Technique/Scientifique/R&D chez EIGER BIOPHARMACEUTICALS
59 ans
Health Technology
Government
Consumer Services

Profil

Christopher Kurtz is currently the Chief Technical Officer at Eiger BioPharmaceuticals, Inc. He previously held positions such as Senior Director-Process Engineering at ALZA Corp., Director-Operations Engineering at Nektar Therapeutics, Head-Commercial API Manufacturing at Gilead Sciences, Inc., Principal at Hauser, Inc., VP-Global Supply Chain & Sustainment Engineering at Alexza Pharmaceuticals, Inc., Vice President-Manufacturing & Global Supply Chain at Kaleo, Inc., Vice President-Drug Device at AbbVie, Inc., Vice President-Research & Development at Novo Nordisk Delivery Technologies, Inc., Manager-Manufacturing Commercialization at Powderject Pharmaceuticals, Inc., and Executive VP-Technical Operations at Cidara Therapeutics, Inc. He also served as a Member of the United States Army and the US Department of the Navy.
Mr. Kurtz obtained his undergraduate degree from The University of Colorado.

Postes actifs de Christopher Kurtz

SociétésPosteDébut
EIGER BIOPHARMACEUTICALS Directeur Technique/Scientifique/R&D 18/04/2022

Anciens postes connus de Christopher Kurtz

SociétésPosteFin
Directeur Technique/Scientifique/R&D 01/05/2008
ALZA CORPORATION Corporate Officer/Principal 01/06/2006
NEKTAR THERAPEUTICS Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Kurtz

Formation de Christopher Kurtz

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

43

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Government

Government

Health Technology

Powderject Pharmaceuticals, Inc.

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Christopher Kurtz